Herendeen Paul
Insider CIK 1374175 · WCRX Exec. V.P. and CFO, Director · ZTS Exec. V.P. and CFO · ELAN Director · VRX EVP, Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELAN Elanco Animal Health Inc | P Buy | 2026-08-07 | 2026-08-10 | 10,000 | $23.69 | $236.9K | 111,687 | SEC↗ |
| ELAN Elanco Animal Health Inc | P Buy | 2026-08-07 | 2026-08-10 | 10,000 | $23.68 | $236.8K | 111,687 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2026-05-21 | 2026-05-26 | 12,196 | — | $0 | 101,687 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2026-05-21 | 2026-05-26 | 4,678 | — | $0 | 89,491 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2025-11-28 | 2025-12-02 | 10,314 | — | $0 | 84,813 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2024-11-29 | 2024-12-03 | 18,169 | — | $0 | 74,499 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2023-11-30 | 2023-12-04 | 20,374 | — | $0 | 56,330 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2022-11-30 | 2022-12-02 | 18,649 | — | $0 | 35,956 | SEC↗ |
| ELAN Elanco Animal Health Inc | P Buy | 2022-09-09 | 2022-09-09 | 10,000 | $15.03 | $150.3K | 17,307 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2021-11-30 | 2021-12-02 | 7,307 | — | $0 | 7,307 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2021-03-10 | 2021-03-10 | 59,519 | $32.97 | $1.96M | 386,618 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise deriv | 2021-03-08 | 2021-03-10 | 49,324 | — | $0 | 0 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise | 2021-03-08 | 2021-03-10 | 49,324 | — | $0 | 395,619 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2021-03-08 | 2021-03-10 | 50,518 | — | $0 | 446,137 | SEC↗ |
| BHC Bausch Health Companies In | A Award deriv | 2021-03-03 | 2021-03-05 | 91,684 | — | $0 | 91,684 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2021-03-03 | 2021-03-05 | 63,439 | — | $0 | 346,295 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2021-03-01 | 2021-03-03 | 15,755 | $31.42 | $495.0K | 282,856 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2020-09-15 | 2020-09-16 | 1,642 | $15.91 | $26.1K | 298,611 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2020-03-09 | 2020-03-11 | 9,328 | $20.96 | $195.5K | 300,253 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2020-02-28 | 2020-03-03 | 7,167 | $24.44 | $175.2K | 309,581 | SEC↗ |
| BHC Bausch Health Companies In | A Award deriv | 2020-02-26 | 2020-02-28 | 159,192 | — | $0 | 159,192 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2020-02-26 | 2020-02-28 | 63,030 | — | $0 | 316,748 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2019-09-16 | 2019-09-18 | 1,642 | $23.24 | $38.2K | 253,718 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2019-08-23 | 2019-08-27 | 24,625 | $22.40 | $551.6K | 255,360 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2019-03-08 | 2019-03-12 | 9,796 | $23.56 | $230.8K | 279,985 | SEC↗ |
| BHC Bausch Health Companies In | A Award deriv | 2019-02-27 | 2019-03-01 | 124,002 | — | $0 | 124,002 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2019-02-27 | 2019-03-01 | 62,915 | — | $0 | 289,781 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2018-09-14 | 2018-09-17 | 10,000 | — | $0 | 226,866 | SEC↗ |
| BHC Bausch Health Companies In | P Buy | 2018-09-14 | 2018-09-17 | 10,000 | $22.61 | $226.1K | 216,866 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2018-08-23 | 2018-08-27 | 24,626 | $22.37 | $550.9K | 206,866 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2018-03-13 | 2018-03-13 | 15,000 | $16.10 | $241.5K | 231,492 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2018-03-07 | 2018-03-09 | 177,482 | — | $0 | 177,482 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2018-03-07 | 2018-03-09 | 79,556 | — | $0 | 79,556 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2018-03-07 | 2018-03-09 | 59,667 | — | $0 | 216,492 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2017-08-23 | 2017-08-25 | 17,175 | $14.14 | $242.9K | 156,825 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2017-03-14 | 2017-03-16 | 24,000 | $10.72 | $257.3K | 174,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2016-08-22 | 2016-08-24 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2016-08-22 | 2016-08-24 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2016-07-19 | 2016-07-20 | 531 | $15.91 | $8.4K | 5,828 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2016-04-15 | 2016-04-19 | 1,513 | $15.40 | $23.3K | 5,297 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2016-03-03 | 2016-03-04 | 2,013 | $13.22 | $26.6K | 3,784 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2016-02-19 | 2016-02-23 | 15,937 | $41.83 | $666.6K | 41,523 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2016-02-19 | 2016-02-23 | 59,577 | — | $0 | 161,626 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2016-01-13 | 2016-01-14 | 569 | $13.85 | $7.9K | 1,771 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2015-10-13 | 2015-10-14 | 582 | $13.54 | $7.9K | 1,203 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2015-07-09 | 2015-07-10 | 532 | $14.79 | $7.9K | 621 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2015-04-09 | 2015-04-10 | 89 | $14.78 | $1.3K | 89 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2015-02-27 | 2015-03-03 | 51,413 | — | $0 | 102,049 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2015-02-27 | 2015-03-03 | 13,018 | $46.09 | $600.0K | 25,394 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2014-09-02 | 2014-09-03 | 50,636 | — | $0 | 50,636 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2014-09-02 | 2014-09-03 | 12,330 | $35.48 | $437.5K | 12,330 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer | 2013-10-01 | 2013-10-01 | 94,900 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 479,430 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 111,920 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 56,710 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 49,180 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 73,330 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 129,340 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 36,610 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer | 2013-09-30 | 2013-10-01 | 37,720 | — | $0 | 94,900 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2013-02-28 | 2013-03-01 | 4,674 | $13.46 | $62.9K | 132,620 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2013-02-19 | 2013-02-21 | 1,969 | $14.53 | $28.6K | 137,294 | SEC↗ |
| WCRX Warner Chilcott plc | A Award deriv | 2013-02-13 | 2013-02-15 | 129,340 | — | $0 | 129,340 | SEC↗ |
| WCRX Warner Chilcott plc | A Award deriv | 2013-02-13 | 2013-02-15 | 36,610 | — | $0 | 36,610 | SEC↗ |
| WCRX Warner Chilcott plc | A Award | 2013-02-13 | 2013-02-15 | 37,720 | — | $0 | 139,263 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2013-02-01 | 2013-02-04 | 2,840 | $14.18 | $40.3K | 101,543 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2013-01-30 | 2013-01-31 | 2,208 | $13.38 | $29.5K | 104,383 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2013-01-22 | 2013-01-23 | 4,305 | $13.50 | $58.1K | 106,591 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2012-09-11 | 2012-09-12 | 309,240 | $13.10 | $4.05M | 110,896 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2012-03-01 | 2012-03-02 | 1,827 | $17.00 | $31.1K | 420,136 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2012-02-21 | 2012-02-23 | 1,933 | $16.82 | $32.5K | 421,963 | SEC↗ |
| WCRX Warner Chilcott plc | A Award deriv | 2012-01-31 | 2012-02-02 | 73,330 | — | $0 | 73,330 | SEC↗ |
| WCRX Warner Chilcott plc | A Award | 2012-01-31 | 2012-02-02 | 58,520 | — | $0 | 423,896 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2012-01-30 | 2012-01-31 | 2,187 | $16.45 | $36.0K | 365,376 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2012-01-23 | 2012-01-24 | 4,149 | $17.32 | $71.9K | 367,563 | SEC↗ |